Hazel Hunt Corcept Therapeutics Inc (CORT) insider trading activity

Hazel Hunt is Chief Scientific Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 183,405 shares of CORT, which is worth approximately $13.5 Million. The most recent transaction as insider was on Feb 11, 2025, when has been sold 85,176 shares (Common Stock) at a price of $68.11 per share, resulting in proceeds of $5,801,337. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K

54.67% 3M change

96.46% 12M change

Total Value Held $13.5 Million

Hazel Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	SELL Payment of exercise price or tax liability	$5,801,337 $68.11 p/Share	85,176 Reduced 31.71%	183,405 Common Stock
Feb 11 2025	BUY Exercise of conversion of derivative security	$493,500 $3.29 p/Share	150,000 Added 35.84%	268,581 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$1,319,287 $37.94 p/Share	34,773 Reduced 22.67%	118,581 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$168,600 $2.81 p/Share	60,000 Added 28.12%	153,354 Common Stock
Jan 08 2024	SELL Payment of exercise price or tax liability	$818,088 $27.46 p/Share	29,792 Reduced 24.19%	93,354 Common Stock
Jan 08 2024	BUY Exercise of conversion of derivative security	$151,000 $3.02 p/Share	50,000 Added 28.88%	123,146 Common Stock
Aug 14 2023	SELL Open market or private sale	$631,854 $30.89 p/Share	20,455 Reduced 21.85%	73,146 Common Stock
Aug 08 2023	SELL Payment of exercise price or tax liability	$900,531 $30.48 p/Share	29,545 Reduced 23.99%	93,601 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	$151,000 $3.02 p/Share	50,000 Added 28.88%	123,146 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$781,122 $26.04 p/Share	29,997 Reduced 29.08%	73,146 Common Stock
Sep 28 2022	BUY Exercise of conversion of derivative security	$104,000 $2.08 p/Share	50,000 Added 32.65%	103,143 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$435,006 $17.16 p/Share	25,350 Reduced 32.3%	53,143 Common Stock
Jan 26 2022	BUY Exercise of conversion of derivative security	$132,800 $3.32 p/Share	40,000 Added 33.76%	78,493 Common Stock
Jul 14 2021	SELL Payment of exercise price or tax liability	$627,624 $20.59 p/Share	30,482 Reduced 44.19%	38,493 Common Stock
Jul 14 2021	BUY Exercise of conversion of derivative security	$144,500 $2.89 p/Share	50,000 Added 42.03%	68,975 Common Stock
Nov 24 2020	SELL Payment of exercise price or tax liability	$714,428 $22.88 p/Share	31,225 Reduced 62.2%	18,975 Common Stock
Nov 24 2020	BUY Exercise of conversion of derivative security	$198,000 $3.96 p/Share	50,000 Added 49.9%	50,200 Common Stock

Hazel Hunt

Chief Scientific Officer

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account